New diagnostic strategy aims to end diagnostic odyssey for rare diseases

NCT ID NCT03163771

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new approach to diagnose peroxisomal disorders, a group of rare genetic diseases. The strategy uses advanced metabolic and genetic tests to find the cause faster in people with suspicious symptoms or lab results. Researchers included 8 participants from four hospitals in France to see if this method could reduce the long delays often faced by these patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIAGNOSES DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease peroxisomal disease Peroxisomal Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Département de Pédiatrie, Unité de Génétique Clinique, CHU d'Amiens

    Amiens, 80054, France

  • Hôpital Jeanne de Flandres, CHRU

    Lille, France

  • Pédiatrie, CHU Clémenceau de Caen

    Caen, 40433, France

  • Pédiatrie, Pavillon Mère et Enfant, CHU Ch. Nicolle de Rouen

    Rouen, 76031, France